Associate Laboratory Director at Natera

Austin, Texas, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, GeneticsIndustries

Requirements

MD/DO and/or PhD in genetics or related field
Current California license/eligibility as a Clinical Genetic Molecular Biologist Scientist or Clinical Cytogeneticist Scientist
ABMGG board-certified/eligible in Clinical Cytogenetics and/or Molecular Genetics, ABP board-certified/eligible in Molecular Genetic Pathology or equivalent doctoral-level board preferred; HCLD (ABB) Certification considered
Current Certificate of Qualification in Genetic Testing from the NYS CLEP preferred
2 or more years of experience in a CLIA-certified clinical laboratory setting analyzing
Complete training relating to HIPAA/PHI privacy, General Policies and Procedure Compliance training, and security training within the first 30 days of hire
Maintain current status on Natera training requirements

Responsibilities

Review, approve, and sign-out reports for clinical molecular/cytogenetic and/or oncologic results, including NIPT, carrier screening, PGD/PGS, products of conception, and oncology testing on platforms including SNP array analysis, NGS, and other methodologies
Oversee the review of genetic and CNV variant data; interpret NGS and microarray results in the context of medical literature, online variant databases, other references, and relevant patient demographic data
Provide clinical and technical support for genetic counselors and other laboratory personnel
Set standards for laboratory testing and acceptable levels of analytic performance and ensure these are maintained
Analyze lab data; contribute to or write publications for high-quality scientific journals
May serve as Technical Supervisor, ensuring: appropriate test method selection; adequate method verification; enrollment in CMS-approved proficiency testing (PT) program; PT samples tested per CLIA requirements; PT results returned timely; PT reports reviewed; corrective actions for unacceptable PT results; quality assessment and control programs maintained; acceptable analytical test performance maintained; remedial actions for deviations documented; patient results reported only when system functions properly; personnel trained and competent prior to testing; policies for monitoring personnel competency in all testing phases; remedial training/education provided; approved procedure manual available
Manage a team: review and approve assigned work; mentor and develop personnel, including succession planning and contingency management
Work with PHI in paper and electronic form; access various technologies to access PHI to perform the job

Skills

NGS

SNP array analysis

Microarray

CNV variant interpretation

NIPT

Carrier screening

PGD/PGS

Products of conception testing

Oncology testing

CLIA compliance

Proficiency testing

Quality control

Genetic counseling support

Lab data analysis

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free